Skip to main content

Table 1 Demographic and clinical characteristics of follow-up COVID-19 patients

From: Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients

Characteristics COVID-19 follow-up patients P
Category (n) Mild (59) Severe/Critical (48)
Age, years 65 (51, 69) 66 (62, 74) n.s.
Male 28 (47%) 25 (52%) n.s.
Female 31 (53%) 23 (48%) n.s.
Comorbidities
 2-DM 6 (10%) 6 (12%) n.s.
 Hypertension 21 (36%) 23 (48%) n.s.
 CVD 6 (10%) 8 (16%) n.s.
Gastrointestinal diseases 4 (7%) 2 (4%) n.s.
Follow-up (days) 93 (82, 96) 101 (96, 118) n.s.
Cholesterol-lowering drugs 9 (15%) 7 (18%) n.s.
  1. Data are presented as median (IQR) or n (%); n.s. no significance, CVD cardiovascular disease, and 2-DM = type-2 diabetes mellitus. Chi-Square test is used